Literature DB >> 81674

Restricted autologous lymphocytotoxicity in lung neoplasia.

B M Vose, F Vánky, M Fopp, E Klein.   

Abstract

Blood lymphocytes from 47 patients with lung carcinoma have been tested for cytotoxicity against cells isolated from the autologous tumour. Significant cytotoxic potential was found in 15 cases. The effectors were also tested against allogeneic tumour targets from lung and other sites. Reactions were only rarely detected (2/32 positive against lung and 1/13 positive against non-lung cells). The restriction of cytotoxicity to the autologous combination was also apparent in in vitro-generated effectors. Blood lymphocytes were co-cultivated with autologous tumour and subsequently tested against autologous or allogeneic targets. Cytotoxicity was found in 13/17 lung tumours against autologous tumour, with no reactions recorded against allogeneic tumour targets, but one case positive against the K562 cell line. These data suggest either the expression of individually distinct antigens on human pulmonary neoplasms, or the requirement for histocompatibility between target and effector in cytotoxicity reactions in man, and therefore differ from previously described patterns of lymphocytotoxicity against human tumours.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 81674      PMCID: PMC2009731          DOI: 10.1038/bjc.1978.217

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  22 in total

1.  Inhibition of human leukocyte migration in agarose by kcl extracts of carcinoma of the lung.

Authors:  A W Boddie; E C Holmes; J A Roth; D L Morton
Journal:  Int J Cancer       Date:  1975-05-15       Impact factor: 7.396

2.  Y-antigen killing by T cells of women is restricted by HLA.

Authors:  E Goulmy; A Termijtelen; B A Bradley; J J van Rood
Journal:  Nature       Date:  1977-04-07       Impact factor: 49.962

3.  Cytotoxity of non-T versus T-lymphocytes from melanoma patients and healthy donors on short- and long-term cultured melanoma cells,.

Authors:  J E de Vries; S Cornain; P Rumke
Journal:  Int J Cancer       Date:  1974-10-15       Impact factor: 7.396

4.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

5.  Demonstration of cell-mediated immunity to human neoplasms of various histological types.

Authors:  I Hellström; K E Hellström; H O Sjögren; G A Warner
Journal:  Int J Cancer       Date:  1971-01-15       Impact factor: 7.396

6.  Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Nature       Date:  1974-04-19       Impact factor: 49.962

7.  Delayed-hypersensitivity reactions to soluble membrane antigens of human malignant lung cells.

Authors:  A C Hollinshead; T H Stewart; R B Herberman
Journal:  J Natl Cancer Inst       Date:  1974-02       Impact factor: 13.506

8.  Cytotoxicity of a factor isolated from human spleen.

Authors:  C B Lozzio; B B Lozzio
Journal:  J Natl Cancer Inst       Date:  1973-02       Impact factor: 13.506

9.  Cell-mediated cytotoxicity to human pulmonary neoplasms.

Authors:  B M Vose; M Moore; G D Jack
Journal:  Int J Cancer       Date:  1975-02-15       Impact factor: 7.396

10.  Reactivity of peripheral blood leukocytes against human foetal cells. II. Cytotoxic potential of preparations enriched or depleted of different leukocyte populations.

Authors:  B M Vose; M Moore
Journal:  Int J Cancer       Date:  1977-01       Impact factor: 7.396

View more
  15 in total

1.  Prognostic significance of immunological tests in lung cancer.

Authors:  I J Check; R L Hunter; T Karrison; T R DeMeester; H M Golomb; J Vardiman
Journal:  Clin Exp Immunol       Date:  1981-02       Impact factor: 4.330

2.  Auto-tumor lysis by blood lymphocytes in vitro. Strongly activated lymphocytes lack selectivity.

Authors:  F Vánky; E Klein
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

Review 3.  Activation of lymphocyte anti-tumour responses in man: effector heterogeneity and the search for immunomodulators.

Authors:  B M Vose
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

4.  Correlation between lymphocyte-mediated auto-tumor reactivities and the clinical course. II. Evaluation of 69 patients with lung carcinoma.

Authors:  F Vánky; A Péterffy; K Böök; J Willems; E Klein; G Klein
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

5.  Tumour-reactive lymphocytes stimulated in mixed lymphocyte and tumour culture. Clonal analysis of effector cells in cytotoxic and proliferative assays.

Authors:  B M Vose; W White
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

6.  The effect of radiotherapy on the natural killer (NK)-cell activity of cancer patients.

Authors:  K McGinnes; J Florence; R Penny
Journal:  J Clin Immunol       Date:  1987-05       Impact factor: 8.317

7.  Lysis of autologous tumor cells by blood lymphocytes tested at the time of surgery. Correlation with the postsurgical clinical course.

Authors:  F Vánky; E Klein; J Willems; K Böök; T Ivert; A Péterffy; U Nilsonne; A Kreicbergs; T Aparisi
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

Review 8.  Natural killer cells in human solid tumors.

Authors:  M Introna; A Mantovani
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

Review 9.  The clinical potential of interleukin-2.

Authors:  R T Oliver
Journal:  Br J Cancer       Date:  1988-10       Impact factor: 7.640

10.  Specific and nonspecific immunotherapy as an adjunct to curative surgery for cancer of the lung.

Authors:  A C Hollinshead; T H Stewart
Journal:  Yale J Biol Med       Date:  1981 Sep-Oct
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.